v3.24.2.u1
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2024
Concentration Risk And Geographic Information [Abstract]  
Schedule of Disaggregation of Total Net Product Revenues by Product
The following table presents Total Revenues and disaggregates Net Product Revenues by product.
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
VOXZOGO$183,923 $113,337 $336,812 $201,173 
VIMIZIM178,016 177,392 370,536 366,584 
NAGLAZYME132,049 90,103 237,678 213,124 
PALYNZIQ88,291 74,868 164,000 137,220 
BRINEURA45,309 38,058 84,356 77,202 
ALDURAZYME38,558 40,318 73,820 74,721 
KUVAN28,551 50,622 64,461 101,100 
ROCTAVIAN7,432 — 8,281 — 
Total net product revenues702,129 584,698 1,339,944 1,171,124 
Royalty and other revenues9,900 10,577 20,918 20,566 
Total revenues$712,029 $595,275 $1,360,862 $1,191,690 
Schedule of Disaggregation of Total Net Product Revenues by Geographic Region The table below disaggregates total Net Product Revenues by geographic region, which is based on patient location for the Company's commercial products sold directly by the Company, except for ALDURAZYME, which is marketed and sold exclusively by Sanofi worldwide.
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
United States$227,449 $191,655 $420,448 $358,439 
Europe220,990 183,434 416,738 344,126 
Latin America84,418 75,444 163,012 143,192 
Middle East49,701 25,630 106,776 117,272 
Rest of world81,013 68,217 159,150 133,374 
Total net product revenues marketed by the Company$663,571 $544,380 $1,266,124 $1,096,403 
ALDURAZYME net product revenues marketed by Sanofi38,558 40,318 73,820 74,721 
Total net product revenues$702,129 $584,698 $1,339,944 $1,171,124 
Schedule of Total Net Product Revenue Concentrations Attributed to Largest Customers
The following table illustrates the percentage of the Company’s total Net Product Revenues attributed to the Company’s largest customers for the periods presented.
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
Customer A14 %15 %14 %15 %
Customer B11 %12 %11 %11 %
Customer C10 %10 %9 %9 %
Total35 %37 %34 %35 %